Digoxin Tablets Recalled
The FDA has reported that, like Digitek, more digoxin tablets have been recalled because of the variability of the active ingredient and/or the variability in the size of the tablets:
• Caraco Pharmaceutical Laboratories, a manufacturer of generic pharmaceuticals, recalled some of their digoxin tablets. Included in the recall are 0.125 and 0.25 mg tablets that were distributed prior to March 31, 2009 and which show an expiration date of September, 2011.
Because of the variation in tablet size, these products could contain either more or less than the labeled amount of digoxin. Digoxin has a narrow therapeutic index, which means that small variations in tablet potency could have serious effects. Too much of the drug can cause digoxin toxicity, which can include hypotension and cardiac instability and may lead to death. Too little can lessen the drug's effectiveness, which can also lead to cardiac instability.
Bahe Cook Cantley & Jones personal injury attorney Larry Jones, who is involved in the Digitek litigation, says "I am appalled that we have yet another instance of a manufacturer who has put toxic doses of digoxin in the marketplace."
For more information about your rights against pharmaceutical companies, contact one of the pharmaceutical lawyers at Bahe Cook Cantley & Jones at http://www.kentuckyinjurylaw.com/
